About
The One Health Antimicrobial Resistance Research Programme (OHARP) is jointly funded by the Ministry of Health (MOH); National Environment Agency (NEA); National Parks Board/Animal & Veterinary Service (NParks/AVS); PUB, Singapore’s National Water Agency (PUB); and Singapore Food Agency (SFA). It is administered by the National Centre for Infectious Diseases to support One Health AMR research across the human, animal, food and environmental sectors in Singapore.
The objective of the OHARP is to steer the national One Health antimicrobial resistance (AMR) research agenda; commission multi-disciplinary and multi-sectorial studies that will impact Singapore’s AMR policies and interventions; foster partnerships with academia and harness their expertise to find One Health solutions; and promote synergies and opportunities for collaboration between sectors.
Areas of Focus
The first grant call will focus on three research priority areas:
- Transmission pathways of key AMR organisms across human, animal, food, water and/or other environments in Singapore
- Assessing the socioeconomic impact of AMR on human and animal health, environment and trade
- Understanding the knowledge, attitudes and practices regarding AMR and determine how best to change behaviour to facilitate the control of AMR
Timeline for OHARP Grant Call
Grant Call Opens | 08 Jan 2021 |
Grant Call Closure | 19 Feb 2021, 5pm |
Eligibility
Only one Corresponding Principal Investigator (PI) is allowed per application and is required to fulfil the following criteria at the point of application:
- Holds a primary appointment in a local publicly funded institution and salaried by the institution
- Has no outstanding report from previous BMRC, NMRC grants, and other national grants
- For proposals involving patient care, the PI should be SMC registered; or should be able to demonstrate ability to access patients through SMC registered Co-Is or collaborators
Research should be conducted in more than one sector – human, animal, food and environment – and in Singapore.
Review Procedure
The application will be reviewed by the OHARP Scientific Panel for selection and applicants will be notified of the outcome by end May 2021. Applicants may be invited for an interview by the panel.
Funding Quantum and Duration
Up to $300,000 per project over and up to 3 years.
Submission
Interested applicants are to complete the OHARP Application Package. Please refer to the OHARP Terms & Conditions and Guidelines for the Management of NCID Programmes – OHARP for more details.
It is mandatory for all applications to be submitted and endorsed by the Host Institution's Director of Research (DOR) by 19 February 2021, Friday, 5pm. Submissions should be made to the OHARP Secretariat at oh_amr_research@ncid.sg through the Host Institution's Research Office in the following format:
- 1 file without signatures, including all pictures, tables, charts and various attachments in Word Document format
- 1 file with signatures, including all pictures, tables, charts and various attachments in PDF format
Please be reminded that the OHARP secretariat will not accept late or incomplete submissions or submissions from individual applicants without endorsements from Reporting Officer (RO) / Head of Department (HOD) and Designated Division Endorsers.
Please note that each applicant can only submit one application, and the application must list all the people and groups involved in the project.
Roadshow
Interested applicants are invited to join the OHARP January 2021 Grant Call Roadshow, held on 15 January 2021 (Friday), 4-5 pm on Zoom.
Please click here to register for the Roadshow. Successful registrants will be sent a confirmation email with log-in details.
Contact Us
For enquiries on OHARP, please email us oh_amr_research@ncid.sg
Additional Information
Please refer to the grant application package and documents below which contain important information on the requirements of the OHARP grant:
The NCID Catalyst Grant, funded by the Ministry of Health, Singapore, aims to encourage inter-institutional collaborative research projects, workshops and exchanges in the fields of infectious diseases and public health, between new Principal Investigators and researchers of academic institutions and hospitals. In August 2018, the first three NCID Catalyst grants were awarded to the following investigators:
Principal Investigator | Dr Mo Yin |
Project Title | Understanding the epidemic success of Escherichia coliSequence Type 131 in the community |
Institution | National University Hospital
|
Principal Investigator | Dr Jean Sim Xiang Ying |
Project Title | Tweaking everyday objects to prevent the spread of AMR |
Institution | Singapore General Hospital |
Principal Investigator | Jocelyn Teo |
Project Title | Paving the Way for Personalized Medicine in Infectious Diseases – A multi-systems approach |
Institution | Singapore General Hospital |